Febuxostat reduces muscle wasting in tumor-bearing mice with LM8 osteosarcoma cells via inhibition of reactive oxygen species generation

References

• Fearon K, Strasser F, Anker SD, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12(5):489–495.
   PubMed Web of Science ®Google Scholar
• Murphy KT, Lynch GS. Editorial update on emerging drugs for cancer cachexia. Expert Opin Emerg Drugs. 2012;17(1):5–9.
   PubMed Web of Science ®Google Scholar
• Luzzatto L, Pandolfi PP. Causality and chance in the development of cancer. N Engl J Med. 2015;373(1):84–88.
   PubMed Web of Science ®Google Scholar
• Aggarwal V, Tuli HS, Varol A, et al. Role of reactive oxygen species in cancer progression: molecular mechanisms and recent advancements. Biomolecules. 2019;9(11):735.
   PubMed Web of Science ®Google Scholar
• Hielscher A, Gerecht S. Hypoxia and free radicals: role in tumor progression and the use of engineering-based platforms to address these relationships. Free Radic Biol Med. 2015;79:281–291.
   PubMed Web of Science ®Google Scholar
• Li Y, Zhu Y, Fang J, et al. Apoptin regulates apoptosis and autophagy by modulating reactive oxygen species (ROS) levels in human liver cancer cells. Front Oncol. 2020;10:1026.
   PubMed Web of Science ®Google Scholar
• Zaidieh T, Smith JR, Ball KE, et al. ROS as a novel indicator to predict anticancer drug efficacy. BMC Cancer. 2019;19(1):1224.
   PubMed Web of Science ®Google Scholar
• Fanzani A, Conraads VM, Penna F, et al. Molecular and cellular mechanisms of skeletal muscle atrophy: an update. J Cachexia Sarcopenia Muscle. 2012;3(3):163–179.
   PubMed Web of Science ®Google Scholar
• Powers SK, Smuder AJ, Judge AR. Oxidative stress and disuse muscle atrophy: cause or consequence? Curr Opin Clin Nutr Metab Care. 2012;15(3):240–245.
   PubMed Web of Science ®Google Scholar
• Konishi M, Pelgrim L, Tschirner A, et al. Febuxostat improves outcome in a rat model of cancer cachexia. J Cachexia Sarcopenia Muscle. 2015;6(2):174–180.
   PubMed Web of Science ®Google Scholar
• Malik UZ, Hundley NJ, Romero G, et al. Febuxostat inhibition of endothelial-bound XO: implications for targeting vascular ROS production. Free Radic Biol Med. 2011;51(1):179–184.
   PubMed Web of Science ®Google Scholar
• Tsuda H, Kawada N, Kaimori JY, et al. Febuxostat suppressed renal ischemia-reperfusion injury via reduced oxidative stress. Biochem Biophys Res Commun. 2012;427(2):266–272.
   PubMed Web of Science ®Google Scholar
• Wang S, Li Y, Song X, et al. Febuxostat pretreatment attenuates myocardial ischemia/reperfusion injury via mitochondrial apoptosis. J Transl Med. 2015;13:209.
   PubMed Web of Science ®Google Scholar
• Ritter J, Bielack SS. Osteosarcoma. Ann Oncol. 2010;21(Suppl 7):vii320–325.
   PubMed Web of Science ®Google Scholar
• Durnali A, Alkis N, Cangur S, et al. Prognostic factors for teenage and adult patients with high-grade osteosarcoma: an analysis of 240 patients. Med Oncol. 2013;30(3):624.
   PubMed Web of Science ®Google Scholar
• Baracos VE, Arribas L. Sarcopenic obesity: hidden muscle wasting and its impact for survival and complications of cancer therapy. Ann Oncol. 2018;29(suppl_2):ii1–ii9.
   Web of Science ®Google Scholar
• Kobayashi H, Okuma T, Oka H, et al. Body composition as a predictor of toxicity after treatment with eribulin for advanced soft tissue sarcoma. Int J Clin Oncol. 2019;24(4):437–444.
   PubMed Web of Science ®Google Scholar
• Tan BH, Brammer K, Randhawa N, et al. Sarcopenia is associated with toxicity in patients undergoing neo-adjuvant chemotherapy for oesophago-gastric cancer. Eur J Surg Oncol. 2015;41(3):333–338.
   PubMed Web of Science ®Google Scholar
• Carson JA, Baltgalvis KA. Interleukin 6 as a key regulator of muscle mass during cachexia. Exerc Sport Sci Rev. 2010;38(4):168–176.
   PubMed Web of Science ®Google Scholar
• Patel HJ, Patel BM. TNF-α and cancer cachexia: molecular insights and clinical implications. Life Sci. 2017;170:56–63.
   PubMed Web of Science ®Google Scholar
• Asai T, Ueda T, Itoh K, et al. Establishment and characterization of a murine osteosarcoma cell line (LM8) with high metastatic potential to the lung. Int J Cancer. 1998;76(3):418–422.
   PubMed Web of Science ®Google Scholar
• Xu LN, Xu BN, Cai J, et al. Tumor-associated fibroblast-conditioned medium promotes tumor cell proliferation and angiogenesis. Genet Mol Res. 2013;12(4):5863–5871.
   PubMed Web of Science ®Google Scholar
• Castillero E, Alamdari N, Lecker SH, et al. Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes. Metabolism. 2013;62(10):1495–1502.
   PubMed Web of Science ®Google Scholar
• Menconi M, Gonnella P, Petkova V, et al. Dexamethasone and corticosterone induce similar, but not identical, muscle wasting responses in cultured L6 and C2C12 myotubes. J Cell Biochem. 2008;105(2):353–364.
   PubMed Web of Science ®Google Scholar
• Fahmi AN, Shehatou GS, Shebl AM, et al. Febuxostat protects rats against lipopolysaccharide-induced lung inflammation in a dose-dependent manner. Naunyn-Schmiedeberg's Arch Pharmacol. 2016;389(3):269–278.
   Google Scholar
• Nomura J, Busso N, Ives A, et al. Xanthine oxidase inhibition by febuxostat attenuates experimental atherosclerosis in mice. Sci Rep. 2014;4:4554.
   PubMed Web of Science ®Google Scholar
• Abrigo J, Elorza AA, Riedel CA, et al. Role of oxidative stress as key regulator of muscle wasting during cachexia. Oxid Med Cell Longev. 2018;2018:1–17.
   Web of Science ®Google Scholar
• Argiles JM, Lopez-Soriano FJ, Busquets S. Mediators of cachexia in cancer patients. Nutrition. 2019;66:11–15.
   PubMed Web of Science ®Google Scholar
• Kobayashi J, Uchida H, Kofuji A, et al. Molecular regulation of skeletal muscle mass and the contribution of nitric oxide: a review. FASEB Bioadv. 2019;1(6):364–374.
   PubMedGoogle Scholar
• Khor SC, Abdul Karim N, Ngah WZ, et al. Vitamin E in sarcopenia: current evidences on its role in prevention and treatment. Oxid Med Cell Longev. 2014;2014:914853.
   PubMed Web of Science ®Google Scholar
• Laurent C, Chabi B, Fouret G, et al. Polyphenols decreased liver NADPH oxidase activity, increased muscle mitochondrial biogenesis and decreased gastrocnemius age-dependent autophagy in aged rats. Free Radic Res. 2012;46(9):1140–1149.
   PubMed Web of Science ®Google Scholar
• Qiu J, Fang Q, Xu T, et al. Mechanistic role of reactive oxygen species and therapeutic potential of antioxidants in denervation- or fasting-induced skeletal muscle atrophy. Front Physiol. 2018;9:215.
   PubMed Web of Science ®Google Scholar
• Sadeghi A, Seyyed Ebrahimi SS, Golestani A, et al. Resveratrol ameliorates palmitate-induced inflammation in skeletal muscle cells by attenuating oxidative stress and JNK/NF-kappaB pathway in a SIRT1-independent mechanism. J Cell Biochem. 2017;118(9):2654–2663.
   PubMed Web of Science ®Google Scholar
• Springer J, Tschirner A, Hartman K, et al. Inhibition of xanthine oxidase reduces wasting and improves outcome in a rat model of cancer cachexia. Int J Cancer. 2012;131(9):2187–2196.
   PubMed Web of Science ®Google Scholar
• Tisdale MJ. Cancer cachexia. Curr Opin Gastroenterol. 2010;26(2):146–151.
   PubMed Web of Science ®Google Scholar
• VanderVeen BN, Fix DK, Carson JA. Disrupted skeletal muscle mitochondrial dynamics, mitophagy, and biogenesis during cancer cachexia: a role for inflammation. Oxid Med Cell Longev. 2017;2017:3292087.
   PubMed Web of Science ®Google Scholar
• Pal M, Febbraio MA, Whitham M. From cytokine to myokine: the emerging role of interleukin-6 in metabolic regulation. Immunol Cell Biol. 2014;92(4):331–339.
   PubMed Web of Science ®Google Scholar
• Fearon KC, Glass DJ, Guttridge DC. Cancer cachexia: mediators, signaling, and metabolic pathways. Cell Metab. 2012;16(2):153–166.
   PubMed Web of Science ®Google Scholar
• Hoffmann C, Weigert C. Skeletal muscle as an endocrine organ: the role of myokines in exercise adaptations. Cold Spring Harb Perspect Med. 2017;7(11):a029793.
   PubMed Web of Science ®Google Scholar
• Kataoka H, Yang K, Rock KL. The xanthine oxidase inhibitor Febuxostat reduces tissue uric acid content and inhibits injury-induced inflammation in the liver and lung. Eur J Pharmacol. 2015;746:174–179.
   PubMed Web of Science ®Google Scholar